$3.29
-0.115[-3.38%]
At close: Apr 5
$3.29
0[0.00%]
After Hours: 4:48PM EDT
Acasti Pharma
(NASDAQ:ACST)Acasti Pharma Stock (NASDAQ:ACST), Earnings Estimates, EPS, and Revenue
Acasti Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS
$-0.210
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Acasti Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06/21/2024 | AM | ACST | Q4 | -$0.66 | — | — | — | $0.00 | — | — | — | Get Alert |
| 02/12/2024 | AM | ACST | Q3 | -$0.52 | — | -$0.21 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/13/2023 | AM | ACST | Q2 | -$0.66 | — | -$0.43 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2023 | AM | ACST | Q1 | -$0.60 | -$0.09 | -$0.54 | -500.00% | $0.00 | — | $0.00 | — | Get Alert |
| 06/23/2023 | AM | ACST | Q4 | -$0.24 | -$0.66 | -$0.66 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
| 02/14/2023 | AM | ACST | Q3 | -$0.54 | -$0.66 | -$0.54 | 18.18% | $0.00 | — | $0.00 | — | Get Alert |
| 11/14/2022 | AM | ACST | Q2 | $0.18 | — | -$0.66 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2022 | AM | ACST | Q1 | -$0.48 | — | -$0.60 | — | $0.00 | — | $0.00 | — | Get Alert |
| 06/21/2022 | AM | ACST | Q4 | -$0.96 | -$0.60 | -$0.24 | 60.00% | $0.00 | — | $0.00 | — | Get Alert |
| 02/14/2022 | AM | ACST | Q3 | -$1.44 | -$1.92 | -$0.54 | 71.88% | $0.00 | — | $0.00 | — | Get Alert |
| 11/10/2021 | AM | ACST | Q2 | -$0.05 | — | $0.18 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2021 | AM | ACST | Q1 | -$2.40 | -$7.68 | -$0.48 | 93.75% | $0.00 | — | $0.00 | — | Get Alert |
| 06/22/2021 | AM | ACST | Q4 | $17.76 | -$7.68 | -$0.96 | 87.50% | $0.00 | — | $0.00 | — | Get Alert |
| 02/09/2021 | AM | ACST | Q3 | -$8.64 | — | -$1.44 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/16/2020 | AM | ACST | Q2 | -$12.48 | — | -$0.05 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/13/2020 | AM | ACST | Q1 | -$7.20 | — | -$2.40 | — | $0.00 | — | $0.00 | — | Get Alert |
| 06/29/2020 | AM | ACST | Q4 | -$8.16 | -$7.68 | $17.76 | 331.25% | $0.00 | — | $0.00 | — | Get Alert |
| 02/14/2020 | AM | ACST | Q3 | -$2.40 | — | -$8.64 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/13/2019 | AM | ACST | Q2 | -$22.56 | -$7.68 | -$12.48 | -62.50% | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is Acasti Pharma (NASDAQ:ACST) reporting earnings?
Acasti Pharma (ACST) is scheduled to report earnings on June 21, 2024. The last reported earnings were for reported on February 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Acasti Pharma (NASDAQ:ACST)?
The Actual EPS was $-0.21, which missed the estimate of $0.00.
What were Acasti Pharma’s (NASDAQ:ACST) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.